Core Viewpoint - The article highlights the strong launch of three new mass spectrometry imaging products by Qiansimeite, promoting the application of domestic instruments in life sciences [1][2]. Group 1: Product Launch and Innovation - Qiansimeite introduced three new devices in the TrySmet mass spectrometry imaging product line during the China Mass Spectrometry Academic Conference on September 20, 2025, aimed at providing higher spatial resolution and ionization efficiency solutions [2][3]. - The new products include the Zenith X AP MALDI ion source, HighSens 10 Nano-DESI ion source, and Atomi zer matrix spray instrument, showcasing advancements in domestic mass spectrometry imaging technology [4][9]. - The Zenith X AP MALDI achieves high-resolution imaging at 10μm in ambient conditions, enhancing sample stability and reducing matrix volatility [11][12]. - The HighSens 10 Nano-DESI overcomes conventional resolution limitations, also achieving 10μm spatial resolution while ensuring detection sensitivity through innovative photolithography technology [13][15]. - The Atomi zer matrix spray instrument integrates automated matrix spraying and a unique "laser transfer" function, which is a first in the industry, improving ionization efficiency and sensitivity [16][19]. Group 2: Market Position and Strategy - Qiansimeite's entry into the mass spectrometry imaging sector is a strategic move driven by market trends and the need for self-reliance in technology, especially amid global supply chain uncertainties [7][21]. - The company has transitioned from collaborative development to fully independent research and development, emphasizing a culture of efficiency and accountability with a "one project per year" approach [8][23]. - Qiansimeite is the only domestic company developing AP MALDI technology, with key components like lenses and ion transmission tubes now produced in-house, despite some reliance on imported lasers [21][22]. Group 3: Application and Future Outlook - The applications of mass spectrometry imaging are expanding beyond drug metabolism and cancer research to include plant science, environmental pollution detection, new materials, and semiconductor analysis [20][24]. - The company is actively pursuing international markets, having participated in exhibitions in Russia and Dubai, and has achieved CE and UL certifications, indicating high product standards [22][24]. - Qiansimeite plans to maintain high R&D investment, with nearly 18 million yuan allocated for 2024, and aims to enhance its competitive edge in the global scientific instrument market [23][24].